Introduction . Given the heterogeneity of somatotroph tumors (STs), it is important to study diverse predictors of morphological identification and sensitivity to first-generation somatostatin receptor ligands (fg-SRLs). Aim . Comparative analysis of the prognostic significance of predictors of STs pathomorphological status and the prospects for using fg-SRLs in patients with acromegaly. Materials and methods . A retrospective analysis of the long-term efficacy of fg-SRLs was conducted in 634 patients with acromegaly. Treatment outcomes were compared with baseline clinical examination data, pharmacotherapeutic testing (PharmT) results (n = 496), cytological and immunohistochemical analysis data (n = 104), as well as quantitative indicators of relative tumor signal intensity (RTSI) on T2- and T1-weighted MRI (n = 106). Results . Among the markers of morphological stratification of STs, the most informative are: age at diagnosis (AUC 0.686), tumor volume and maximum diameter (0.664 and 0.665), expression of the 2nd subtype of somatostatin receptors (SSTR2; 0.816), the difference and ratio of SSTR2 and SSTR5 (0.826 and 0.808), the proportion of cells with antibodies to GH (0.932) and with fibrous bodies (FB; 0.962), tumor cell composition (0.935), RTSI on T2-, T1- and (T2-T1)-weighted MRI (WI; 0.878, 0.822 and 0.918). Predictors of fg-SRLs efficacy include: volume and maximum diameter of STs (0.640 and 0.649), baseline IGF-1 index value (0.637), absolute and relative expression of SSTR2 (0.673, 0.688 and 0.713), proportion of cells with FB (0.698), tumor cell composition (0.742), results of RTSI on T2- and (T2-T1)-WI (0.684 and 0.636) and PharmT (%∆IGF-1 after 3–6 months – 0.840–0.849). The successful use of pegvisomant in patients refractory to fg-SRLs has been demonstrated. Conclusions . Priority predictors of the morphofunctional status of STs and the long-term effectiveness of fg-SRLs simplifying the differential diagnosis of the relevant histotype and facilitating the management of acromegaly treatment have been identified.
BACKGROUND: One of the leading principles of asthenopia treatment is a comprehensive approach based on multidirectional methods of physical impact on the organ of vision. This provision determines the relevance of considering ophthalmochromotherapy, the use of which is determined from the position of photobiomodulation as a non-thermal biological process activated by certain wavelengths of light. AIM: To evaluate the clinical efficacy of ophthalmochromotherapy in the complex rehabilitation treatment of patients with computer vision syndrome. MATERIALS AND METHODS: The study involved 132 patients with computer vision syndrome, accompanied by characteristic manifestations of accommodative asthenopia — habitual excessive tension of accommodation (HETА) or asthenic form of accommodative asthenopia (AFAA). Patients were divided into four groups — two control groups, which underwent the traditional method of treating accommodative asthenopia and two main groups, which, along with the traditional method, underwent ophthalmochromotherapy (green color for HETА and red color for AFAA, respectively). RESULTS: A significantly higher level of clinical efficacy of restorative treatment was established when ophthalmochromotherapy was included in the traditional method, which is confirmed by more pronounced dynamics of accommodation indices (p 0.01), contrast sensitivity at low (0.5, 1.0 cycles/deg.) frequencies (p 0.01), critical frequency of fusion and flickering (p 0.05), and quality of life (p 0.01). CONCLUSIONS: The use of ophthalmochromotherapy in the complex treatment of patients with computer vision syndrome symptoms may be considered as an effective method of restorative correction of the functional state of the visual analyzer, which is confirmed (in comparison with the traditional method) by a pronounced, statistically significant improvement in the state of the accommodative system of the eye, as well as indices reflecting “sensory” fatigue and the patient’s quality of life. At the same time, in accordance with clinical standardization, the inclusion of ophthalmochromotherapy in the traditional treatment method ensured the achievement of standard indicators of quality of life, which reflects the full achievement of treatment targets from the perspective of the “medical and social” health model.
The article presents a clinical case of a 49-year-old man with a long history of alcohol abuse, type 2 diabetes mellitus and hypertension, who was hospitalized with symptoms of acute heart failure. Coronary angioventriculography excluded significant atherosclerotic lesions of the coronary arteries, revealed apical ballooning of the left ventricle (LV), and suspected takotsubo syndrome (TS). Subsequent examination revealed hyperglycemia, increased troponin I levels, decreased global contractility of the LV myocardium, and signs of obstructive hypertrophic cardiomyopathy (HCM). During inpatient treatment, including infusion therapy, beta-blockers and glucose monitoring, the patient's condition improved. Subsequent studies conducted at the outpatient stage confirmed the presence of HCM with a dynamic decrease in the degree of LV outflow tract obstruction, indicating a complex interaction between ST, HCM and withdrawal syndrome against the background of alcohol dependence. This case emphasizes the importance of differential diagnosis and an integrated approach to the treatment of patients with multiple comorbidities.
Vitamin D plays a central role in calcium regulation and oral health, yet deficiency remains widespread in many regions, including North Africa, despite abundant sunlight. Limited data are available regarding vitamin D status among dental patients in Libya. This study aimed to assess serum vitamin D and calcium levels among patients attending a dental clinic in Sabratha City, Libya, and to examine differences by age, gender, and vitamin D category. A descriptive analytical cross-sectional design was implemented from September to November, during which serum 25-hydroxyvitamin D and calcium were measured, and demographic data were recorded. Data were analyzed using IBM SPSS Statistics version 21, applying descriptive statistics, independent-samples t-tests, and one-way ANOVA with significance set at p < 0.05. Participants ranged in age from 6 to 50 years, with a mean of 20.83 ± 11.22 years. Serum vitamin D levels showed considerable variation, ranging from 3 to 53.8 ng/mL, with a mean of 22.51 ± 10.67 ng/mL; deficiency was identified in 47.2% of patients, insufficiency in 30.6%, and sufficiency in 22.2%. Serum calcium concentrations ranged from 8.3 to 10.1 mg/dL, with a mean of 9.11 ± 0.43 mg/dL. No statistically significant differences in vitamin D or calcium were found between males and females, between age groups, or across vitamin D categories. In conclusion, a notable proportion of dental clinic attendees had low vitamin D levels, whereas serum calcium levels remained within normal limits across all groups. These findings provide useful baseline biochemical information for this population and highlight the broad presence of suboptimal vitamin D levels in the region
Poor water solubility, which negatively influences the bioavailability of oral medications, is typical for the vast majority of molecules (up to 70